Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis

Published:2020-06-18 Issue:1 Volume:24 Page:
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Crit Care

Author:

Yang Xianghong,Jin Yiyang,Li Ranran,Zhang Zhongheng,Sun Renhua,Chen Dechang

Funder

Key Research and Development Plan of Zhejiang province

Zhejiang Medical and Health Technology Platform Project

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13054-020-03065-4.pdf

Reference33 articles.

1. Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 2020. https://doi.org/10.1016/j.kint.2020.03.001 .

2. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv. 2020; doi: https://doi.org/10.1101/2020.02.18.20023242:2020.02.18.20023242 .

3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585 .

4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.

5. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. https://doi.org/10.1016/s2213-2600(20)30079-5 .

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proximal tubular dysfunction as a predictor of AKI in Hospitalized COVID-19 patients;PLOS ONE;2024-06-06

2. Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression;PLOS ONE;2024-06-06

3. Application of boosted trees to the prognosis prediction of COVID‐19;Health Science Reports;2024-05

4. Patients with COVID-19 Infection and Stroke have Higher than Expected Mortality, Regardless of the Primary Presentation;2024-03-30

5. A meta‐analysis of risk factors for acute kidney injury in pneumonia: Effectiveness of nursing interventions;Therapeutic Apheresis and Dialysis;2024-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3